Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. The muted market ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Farer has brought back its popular Maze GMT after a two-year hiatus, and the brand fixed the watch's biggest issue.

An anonymous coder, writing to 404media under the fake name Aaron B, has also been feeling the malaise, and he's doing ...

Just kidding, all you need to do is click your mouse, and your avatar will do all the walking in the Maze Simulator. You can never be entirely sure you’ve typed in a code correctly if you’re ...

A Quick Take On Maze Therapeutics, Inc. Maze Therapeutics, Inc. (MAZE) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The company is ...

Lines of tractors have taken to roads across Northern Ireland to protest against proposed changes to inheritance tax rules.